ENDRA Life Sciences Inc. (NDRA) a un PER historique négatif de -0.6, ce qui signifie que l'entreprise est actuellement non rentable sur la base des douze derniers mois (TTM). Le rendement bénéficiaire historique est de -176.29%.
Critères prouvés par cette page:
Score Global SharesGrow : 62/100 avec 4/7 critères réussis.
| Year | P/E (TTM) | Ratio PEG | Ratio P/B | Ratio P/S | Rendement du Dividende |
|---|---|---|---|---|---|
| 2016 | -9,607.9 | -441.43 | -29,834.86 | 51,719.05 | - |
| 2017 | -6,193.0 | -66.37 | 6,312.08 | 94,701.98 | - |
| 2018 | -1,207.1 | -20.70 | 1,892.58 | 1,915,331.63 | - |
| 2019 | -1,657.1 | 358.55 | 4,631.69 | 0.00 | 0.02% |
| 2020 | -2,148.3 | 30.72 | 3,513.55 | 0.00 | 0.00% |
| 2021 | -4,411.2 | 78.58 | 4,594.02 | 0.00 | 0.00% |
| 2022 | -1,043.2 | 63.41 | 1,908.36 | 0.00 | 0.00% |
| 2023 | -629.9 | -21.81 | 1,119.73 | 0.00 | 0.00% |
| 2024 | -0.6 | -0.01 | 2.74 | 0.00 | 0.07% |
| 2025 | -0.5 | 0.04 | 1.58 | 0.00 | - |
| Year | EPS (Dilué) | Chiffre d'Affaires | Résultat Net | Marge Nette |
|---|---|---|---|---|
| 2016 | $-14.21 | $515.58K | $-2.78M | -538.3% |
| 2017 | $-27.47 | $351.62K | $-5.38M | -1529.2% |
| 2018 | $-43.49 | $6.17K | $-9.8M | -158669.6% |
| 2019 | $-41.48 | $0.00 | $-15.55M | - |
| 2020 | $-12.47 | $0.00 | $-11.97M | - |
| 2021 | $-5.47 | $0.00 | $-11.19M | - |
| 2022 | $-4.57 | $0.00 | $-13.2M | - |
| 2023 | $-5.89 | $0.00 | $-10.06M | - |
| 2024 | $-56.94 | $0.00 | $-11.51M | - |
| 2025 | $-8.93 | $0.00 | $-7.03M | - |
| Year | EPS (Moy.) | Fourchette EPS | CA (Moy.) | Fourchette CA | Analystes |
|---|---|---|---|---|---|
| 2026 | $-4.65 | $-4.65 – $-4.65 | $100K | $100K – $100K | 1 |
| 2027 | $-4.00 | $-4.00 – $-4.00 | $100K | $100K – $100K | 1 |
